Investigator #217 — Durham, North Carolina

Investigator #217 is a clinical research site located in Durham, North Carolina, United States 27704.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Investigator #217 has participated in 1 clinical trials.

Therapeutic areas: Kerato Conjunctivitis Sicca.

Sponsors: Kala Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator #217?

Investigator #217 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator #217 conducted?

Investigator #217 has 1 clinical trials on record. Their work covers Kerato Conjunctivitis Sicca.

Is Investigator #217 accredited by Crixeo Health?

Investigator #217 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator #217?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.